Prognostic significance of HLA-DR antigen in dysplasia, carcinoma in situ and invasive carcinoma of the gallbladder

East African Medical Journal

Volumn 80, Issue 11, 2003, Pages 554-558

  Tamiolakis, D ^a   Simopoulos, C ^b   Kotini, A ^c   Venizelos, J ^d   Jivannakis, T ^e   Skaphida, P ^a   Papadopoulos, N ^c  

^a UNIVERSITY GENERAL HOSPITAL OF ALEXANDROUPOLIS   (Greece)

^b Department of Surgery ^*  (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d Ippokration Hospital Thessaloniki   (Greece)

^e General Hospital of Drama   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CARCINOMA; EPITHELIUM; GALLBLADDER TUMOR; HUMAN; IMMUNOLOGY; PATHOLOGY; PROGNOSIS;

ANTIGENS, CD4; CARCINOMA; EPITHELIUM; GALLBLADDER NEOPLASMS; HLA-DR ANTIGENS; HUMANS; PROGNOSIS;

EID: 4644338798     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Frelinger, J.A. Tissue distribution and cellular expression of 1a antigens. In: Ferrone S., David C.S., eds. 1a Antigens I Mice. Florida: CRC Press, Boca Raton, 1983.
2. Lafuse, W.P. and David, C.S. 1a antigens. Genes, molecules, and function. Transplantation 1984; 38:443-553.
3. Daar, A.S., Fuggle, S.V., Fabre, J.W., Ting, A. and Morris, P.J. The detailed distribution of MHC class II antigens in normal human organs. Transplantation. 1984; 38:293-298.
4. Klein, J, Figuerou, F. and Nagy, A. Genetics of the major histocompatibility complex: the final act. Annual Review of Immunology 1983; 1:119-142.
5. Steinmetz, M. and Hood, L. Genes of the major histocompatibility complex in mouse and man. Science. 1983; 222:727-733.
6. O'Neil, D.A., Porter, E.M., Elewaut, D., et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium . J. Immunol. 1999; 163:6718-6724.
7. Eisenhauer, P.B., Harwig, S.S. and Lehrer, R.I. Cryptdins: antimicrobial defensins of the murine small intestine. Infect. Immun. 1992; 60:3556-3565.
8. Andoh, A., Fujiyama, Y., Bamba, T. and Hosoda, S. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol. 1993; 51:4239-4247.
9. Hershberg, R.M., Framson, P.E., Cho, D.H., et al. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J. Clin. Invest. 1997; 100:204-215.
10. Bland, P.W. and Warren, L.G. Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-1a antisera. Immunology. 1986; 58:1-7.
11. Kelley, V.R. and Singer, G.G. The antigen presentation function of renal tubular epithelial cells. Exp. Nephrol. 1993; 1:102-111.
12. Nickoloff, B.J. and Turka, L.A. Immunological functions of non-professional antigen presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today. 1994; 15:464-469.
13. Savage C.O., Brooks C.J., Harcourt G.C., et al. Human vascular endothelial cells process and present autoantigen to human T cell lines. Int Immunol. 1995; 7:471-479.
14. Berin, M.C., Kiliaan, A.J., Yang, P.C., et al. Rapid transepithelial antigen transport in rat jejunum: impact of sensitization and the hypersensitivity reaction. Gastroenterology 1997; 113:856-864.
15. Dickinson, B.L., Badizadegan, K., Wu, Z., et al. Bidiredional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J. Clin. Invest. 1999; 104:903-911.
16. Israel, E.J., Taylor, S., Wu, Z., Mizoguchi, E., Blumberg, R.S., Bhan, A. et al. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology. 1997; 92:69-74.
17. Givan, A.L., White, H.D., Stem, J.E., et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Amer. J. Reprod. Immunol. 1997; 38:350-359.
18. Yeaman, G.R., Guyre, P.M., Fanger, M.W., et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J. Leukoc Biol. 1997; 61:427-435.
19. Poppe, W.A., Drijkoningen, M., Ide, P.S., Lauweryns, J.M., Van, and Assche, F.A. Lymphocytes and dendritic cells in the normal uterine cervix. An immunohistochemical study. Eur. J. Obstet. Gynecol. Reprod. Biol. 1998; 81:277-282.
20. Kaiserlian, D., Vidal, K. and Revillard, J.P. Murine enterocytes can present soluble antigen to specific class II-restricted CD4+ T cells. Eur. J. Immunol. 1989; 19:1513-1516.
21. Kaiserlian, D. Epithelial cells in antigen. Sampling and presentation in mucosal tissues. Curr. Top. Microbiol. Immunol. 1999; 236:55-78.
22. Dammrich, J., Muller-Hermelink, H.K., Mattner, A., Buchwald, J., and Ziffer, S. Histocompatibillity antigen expression in pulmonary carcinomas as indication of differentiation and of special subtypes. Cancer. 1990; 65:1942-1954.
23. Redondo, M., Concha, A., Oldiviela, R., et al. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters. Cancer Res. 1991; 51:4948-4954.
24. Pantel, K., Schlimok, G., Kutter, D., et al. Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells. Cancer Res. 1991; 51:4712-4715.
25. Goepel, J.R., Rees, R.C., Rogers, K., et al. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma. Brit. J. Cancer. 1991; 64:880-883.
26. van Duinen, S.G., Ruiter, D.J., Broecker, E.B., et al. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res. 1988; 48:1019-1025
27. Brunner, C.A., Gokel, J.M., Riethmullerand, G. and Johnson, J.P. Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognosis. Eur. J. Cancer. 1991; 27:411-416.
28. Esteban, F., Concha, A., Huelin, C., et al. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the Larynx. Int. J. Cancer. 1989; 43:436-442.
29. Natali, P., Bigotti, A., Cavalieri, R., et al. Gene products of the HLA-D region in normal and malignant tissues of non-lymphoid origin. Hum Immunol. 1986; 15:220-233.
30. Connor, M.E. and Stern, P.L. Loss of MHC class-I expression in cervical carcinomas. Int. J. Cancer. 1990; 46:1029-1034.
31. Stein, B., Momburg, F., Schwarz, V., et al. Reduction or loss of HLA-A, B, C antigens in colorectal carcinoma appears not to influence survival. Brit. J. Cancer. 1988; 57:364-368.
32. Wintzer, H.O., Benzing, M. and von Kleist, S. Lacking prognostic significance of microglobulin, MHC class I and class II antigen expression in breast carcinomas. Brit. J. Cancer. 1990; 62:289-295.
33. Ghosh, A.K., Moore, M., Street, A.J., Howat, J.M.T. and Schofreid, P.F. Expression of HLA-D sub-region products on human colorectal carcinoma. Int. J. Cancer. 1986; 38:459-464
34. Kamma, H., Yazawa, T., Ogata, T., Horiguchi, H. and lijima, T. Expression of MHC class II antigens in human lung cancer cells. Virchows Arch. B. Cell Pathol. 1991; 60:407-412.
35. Dammrich, J., Buchwald, J., Papadopoulos, T., and Muller Hermelink, H.K. Special subtypes of pulmonary adenocarcinomas indicated by different tumor cell HLA-expression and stromal infiltrates. Virchows Arch B Cell Pathol. 1991; 61:9-18.
36. Scupoli, M.T., Sartoris, S., Tosi, G., et al. Expression of MHC class I and II antigens in pancreatic adenocarcinomas. Tissue Antigens.1996; 48:(4 Pt 1)301-311.
37. Duarte, I, Llanos, O., Domke, H., Harz, C. and Valdivieso, V. Metaplasia and precursor lesions of gallbladder carcinoma. Frequency, distribution and probability of detection in routine histologic samples. Cancer. 1993; 72:1878-1884.